1061 — Essex Bio-Technology Cashflow Statement
0.000.00%
Last trade - 00:00- HK$2.05bn
- HK$1.61bn
- HK$1.81bn
Annual cashflow statement for Essex Bio-Technology, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 394 | 260 | 346 | 376 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 33 | 37.6 | 3.63 | -6.99 | — |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -50.8 | 43.3 | -70 | -55.6 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 409 | 383 | 339 | 368 | — |
| Capital Expenditures | -255 | -283 | -128 | -119 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -25.2 | -19.1 | 73.7 | 12.9 | — |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -280 | -302 | -54.3 | -107 | — |
| Financing Cash Flow Items | -12.3 | -15.7 | -15.9 | -63.6 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -73.1 | -169 | -310 | -201 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 71.6 | -128 | -33.6 | 47.3 | — |